Patent ID: 11857778
Assignee: CALA HEALTH, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating symptoms of an inflammatory gastrointestinal disease in a patient with transcutaneous stimulation of a peripheral nerve comprising:
positioning a first peripheral nerve effector on the patient's skin to stimulate the peripheral nerve of the patient;
delivering a first electrical nerve stimulation signal transcutaneously to the peripheral nerve through the first peripheral nerve effector;
receiving an input relating to activation of the first peripheral nerve;
calculating one or more features from the input relating to activation at least based in part on a nerve conduction velocity of the first peripheral nerve;
adjusting an electrical stimulation parameter based on one or more features of the nerve conduction velocity of the first peripheral nerve to selectively activate a first preselected nerve fiber type; and
delivering the adjusted electrical stimulation pattern via an electrical nerve stimulation signal through the first peripheral nerve effector to affect at least one brain or spinal cord autonomic feedback loop relating to release of neurotransmitters from an autonomic nervous system that modulate synthesis of inflammatory biomarkers and reduce inflammation relating to the inflammatory gastrointestinal disease.